Search research articles
Contact Us
Filters
Showing results (301-310 of 397) with videos related to
Page
of 40
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
March 23, 2013
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression
Mohan Liu, James N Ingle, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer
Jodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.
Cancers
|
August 28, 2020
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K Gupta, Amber L Collier, Dasom Lee, et al.
Cancer Discovery
|
June 15, 2013
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention
James N Ingle, Mohan Liu, D Lawrence Wickerham, et al.
Breast Cancer Research and Treatment
|
September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
Roberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
Pharmacogenetics and Genomics
|
May 17, 2018
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab
James N Ingle, Krishna R Kalari, Donald Lawrence Wickerham, et al.
Cancer Research
|
October 21, 2016
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
James N Ingle, Fang Xie, Matthew J Ellis, et al.
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Frontiers in Oncology
|
February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
Sara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
Oncogene
|
March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Mohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
Page
of 40
Search research articles
Search
Showing results (301-310 of 397) with videos related to
Sort By:
Page
of 40
Molecular Endocrinology (Baltimore, Md.)
|
March 23, 2013
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression
Mohan Liu, James N Ingle, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer
Jodi M Carter, Mei-Yin C Polley, Roberto A Leon-Ferre, et al.
Cancers
|
August 28, 2020
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K Gupta, Amber L Collier, Dasom Lee, et al.
Cancer Discovery
|
June 15, 2013
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention
James N Ingle, Mohan Liu, D Lawrence Wickerham, et al.
Breast Cancer Research and Treatment
|
September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
Roberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
Pharmacogenetics and Genomics
|
May 17, 2018
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab
James N Ingle, Krishna R Kalari, Donald Lawrence Wickerham, et al.
Cancer Research
|
October 21, 2016
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
James N Ingle, Fang Xie, Matthew J Ellis, et al.
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Frontiers in Oncology
|
February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
Sara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
Oncogene
|
March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Mohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
Page
of 40